Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Transient thyroid dysfunction during chronic viral hepatitis treated with alpha-interferon]

R Luboshitzky1, A Ayash, E Nussinson

  • 1Institute of Endocrinology, Central Emek Hospital, Afula.

Harefuah
|January 15, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of ventromedial hypothalamic lesions on adipose tissue of weanling male rats.

Diabetologia·2016
Same author

Oral administration of non-absorbable delayed release 6-mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn's disease with low rate of side effects: results of double blind Phase II clinical trial.

Clinical and experimental immunology·2015
Same author

Cardiovascular risk factors in primary hyperparathyroidism.

Journal of endocrinological investigation·2009
Same author

Concurrent nonfunctioning parathyroid carcinoma and parathyroid adenoma.

American journal of otolaryngology·2006
Same author

Prevalence and risk factors for asymptomatic bacteriuria in women with Type 2 diabetes mellitus.

Diabetic medicine : a journal of the British Diabetic Association·2006
Same author

Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women: the effect of cyproterone acetate-ethinyl estradiol treatment.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2004
Same journal

[Tennis Elbow Among Players].

Harefuah·2026
Same journal

[Internal Medicine - My Mission].

Harefuah·2026
Same journal

[Treatment of Morbid Obesity in Israel: GLP-1 Agonists Versus Bariatric Surgery - Clinical and Economic Aspects].

Harefuah·2026
Same journal

[Baby steps: Post-operative Treatment Recommendations for Pediatric Tracheostomy in Israel].

Harefuah·2026
Same journal

[Mastoiditis Caused by Fusobacterium Necrophorum: an Unusual Pathogen in a Well-Known Disease].

Harefuah·2026
Same journal

[Cochlear Implantation in Single-Sided Deafness - Six Years of Follow-Up from Diagnosis and Consistent Use, Through Dedicated and Creative Auditory Learning, to the Development of Bilateral Central Processing Abilities].

Harefuah·2026
See all related articles

Alpha-interferon therapy can cause temporary thyroid dysfunction in patients with chronic viral hepatitis. Thyroid function normalized after discontinuing interferon, suggesting a transient effect.

Area of Science:

  • Endocrinology
  • Hepatology
  • Immunology

Background:

  • Chronic viral hepatitis requires treatment, often involving interferon therapies.
  • Thyroid function is crucial for overall health and can be affected by systemic treatments.
  • Autoimmune thyroid disease is a common endocrine disorder.

Observation:

  • Two patients with chronic viral hepatitis developed thyroid dysfunction during alpha-interferon treatment.
  • One patient experienced hypothyroidism, while the other developed hyperthyroidism.
  • These thyroid dysfunctions emerged months after initiating interferon therapy.

Findings:

  • Alpha-interferon treatment was associated with transient hypothyroidism and hyperthyroidism.
  • Thyroid function tests (TSH, FT4, T3) returned to normal within 1-2 months after stopping interferon.

Related Experiment Videos

  • Antimicrosomal antibodies were initially positive in the hypothyroid patient but became negative later.
  • Implications:

    • Alpha-interferon may induce temporary thyroid dysfunction in euthyroid patients.
    • Monitoring thyroid function during interferon therapy is advisable.
    • The transient nature of the dysfunction suggests a reversible mechanism of action.